RP1 rs61754027: Retinitis Pigmentosa Risk Explained
The rs61754027 variant is an uncommon single nucleotide polymorphism located in the RP1 gene on chromosome 8. Alterations in this gene are classically linked to inherited retinal degenerations, specifically autosomal dominant retinitis pigmentosa. Scientific evidence regarding this specific variant's individual pathogenicity remains limited and requires cautious clinical interpretation.
What each genotype means
Typical retinal risk
You carry two copies of the common reference allele at this position in the RP1 gene. This genotype is not linked to autosomal dominant retinitis pigmentosa. Your baseline risk for inherited retinal degeneration from this specific variant remains typical of the general population.
Carried by more than 99.9% of individuals across all major global populations.
Retinitis pigmentosa risk carrier
You carry one copy of the rare alternate allele associated with autosomal dominant retinitis pigmentosa. Scientific literature indicates that single pathogenic truncating or missense changes in this region can lead to progressive retinal degeneration, typically presenting with night blindness and gradual constriction of peripheral vision. However, clinical expressivity and onset age can vary widely, and evidence for specific single-nucleotide substitutions may be limited or subject to reclassification.
Extremely rare globally, observed in fewer than 1 in 10,000 individuals across diverse ancestries in gnomAD.
Elevated retinal risk
You carry two copies of the rare alternate allele in the RP1 gene. Given the autosomal dominant inheritance pattern of pathogenic RP1 variants, carrying two copies is exceptionally rare and may be associated with progressive photoreceptor loss and early-onset visual impairment. In published cohorts, biallelic mutations in RP1 are generally linked to severe rod-cone dystrophy, though specific clinical outcomes depend on the exact functional impact of the alteration.
Virtually absent in public population reference databases such as gnomAD, with expected frequencies far below 1 in 1,000,000.
Genomic Context and the RP1 Gene
The rs61754027 variant is situated within the RP1 gene (retinitis pigmentosa 1), located on the long arm of chromosome 8 at 8q12. The RP1 gene encodes an essential retinal protein belonging to the doublecortin family that plays a fundamental role in regulating microtubule polymerization and photoreceptor architecture. In rod and cone photoreceptors, RP1 is concentrated in the connecting cilium and outer segments, where it maintains the structural alignment of light-detecting discs. Disruptions in the RP1 coding sequence can impair the structural stability of photoreceptors, predisposing individuals to premature rod cell death followed by progressive cone degeneration. Genetic variations in RP1 are historically prominent in inherited retinal dystrophies and can lead to conditions spanning macular dystrophy, cone-rod dystrophy, and classical retinitis pigmentosa.
Associated Vision Conditions and Evidence Strength
Pathogenic alterations in RP1 are well established as causing autosomal dominant retinitis pigmentosa (adRP), a disease characteristically beginning with nyctalopia (night blindness) and advancing toward concentric visual field constriction (tunnel vision). However, the evidence specifically classifying rs61754027 is currently categorized as limited. While prominent nonsense mutations in RP1—such as Arg677Ter—have extensive segregation and experimental evidence confirming dominant disease causality, rarer single-nucleotide alterations like rs61754027 frequently lack large cohort validation. Clinicians and geneticists classify many rare variants in inherited retinal dystrophy panels as variants of uncertain significance (VUS) until familial cosegregation studies or functional assays clearly demonstrate protein malfunction or benign status.
Population Frequency and Rarity
According to broad population datasets, including the Genome Aggregation Database (gnomAD), rs61754027 is extremely rare globally, with an overall minor allele frequency of less than 0.0001 (0.01%). In large multi-ancestry cohorts, the variant is observed only in isolated heterozygous individuals and is completely absent in homozygous form. Such extreme rarity aligns with the characteristics expected of alleles associated with severe, penetrant, dominant retinal disorders, as purifying selection limits their spread in the general population. Because carrier frequencies are minuscule across all continental ancestries, population-level statistical associations must be interpreted carefully alongside individual clinical evaluations and family histories.
Understanding Your Test Results
Identifying the rs61754027 variant on a direct-to-consumer genetic test or an exploratory panel does not equal an automatic diagnosis of retinitis pigmentosa. Consumer arrays carry non-trivial false-positive rates for extremely rare single-nucleotide variants, and clinical confirmation via certified Sanger sequencing or targeted next-generation sequencing is necessary. Furthermore, because evidence for rs61754027 is limited, carrying an atypical allele does not definitively predict future vision impairment. Individuals who possess this variant or have a personal or family history of visual field loss should consult an ophthalmologist or a licensed genetic counselor. Certified specialists can perform specialized visual field assessments, electroretinography, and comprehensive retinal imaging to determine actual ocular health.
How common is this variant?
The rs61754027 variant is exceedingly rare across global populations, documented in the Genome Aggregation Database (gnomAD) at a minor allele frequency of less than 0.0001 (<0.01%). It is virtually unobserved in homozygous form across all major continental ancestry groups.
Frequently asked questions
What is the RP1 gene and why is it important?
The RP1 gene provides instructions for creating a protein essential to the structure and stability of photoreceptor cells in the retina. It helps maintain the connecting cilium of rods and cones, which are the specialized cells that process light for vision.
Does carrying the rs61754027 variant mean I will go blind?
No, carrying this variant is not a guarantee of vision loss. The evidence linking rs61754027 specifically to retinitis pigmentosa is limited, and commercial genetic screening results require clinical confirmation and evaluation by an eye specialist before any diagnosis can be made.
What are the common symptoms of retinitis pigmentosa?
Retinitis pigmentosa typically presents first as night blindness (difficulty seeing in dim light or darkness) during adolescence or early adulthood. Over time, individuals often experience progressive peripheral visual field loss, sometimes resulting in 'tunnel vision'.
What should I do if my raw genetic data shows this variant?
If an unvalidated genetic test shows the rs61754027 variant, you should discuss the findings with a genetic counselor or ophthalmologist. They can order diagnostic-grade clinical testing to verify the result and evaluate your retinal health using electroretinography and dilated eye exams.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs61754027?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29